Quantified Evaluation of Noninvasive System Delivering Microwave Energy for Unwanted Fat Reduction and Skin Tightening in Asians.

Launched by CHANG CHANG CHENG · Apr 6, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new treatment method that uses microwave energy to help reduce unwanted fat and tighten the skin on the face for Asian individuals who are experiencing signs of aging, such as cheek wrinkles and skin laxity. The main goal is to find out how effective this microwave treatment is, how to best measure its results, the safest way to use it, and how long the benefits might last. Participants will receive three treatment sessions, each lasting about 12 minutes, using a device called the "DEKA" ONDA Microwave system.

To be part of this trial, you need to be between 20 and 60 years old and able to understand and follow the study guidelines. It’s important to note that some people may not be eligible, including those with certain medical conditions, pregnant or breastfeeding women, or those who have had specific treatments on their face in the past six months. If you decide to participate, you will need to give your written consent and commit to the entire study. This trial is currently not recruiting participants, but it aims to provide helpful insights into a promising new approach for facial rejuvenation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women aged between 20 and 60.
• • Subjects who are capable of understanding and comply with the study procedures, instructions, and visit schedule.
• • Subjects who voluntarily decide to participate in the entire course of the trial and provide written consent in the Informed Consent Form.
• Exclusion Criteria:
• • Subjects with autoimmune diseases/received immunotherapy and subjects with diabetes mellitus.
• • Subjects with a history of a hypertrophic scar.
• • Pregnant or breastfeeding women.
• • Subjects with untreated epilepsy or underlying porphyria.
• • When there is an active disease (such as inflammation, infection or tumors) in or near the intended treatment site.
• • Treatment procedure (e.g., bioresorbable fillers, laser/light therapies, botulinum toxin A injections, facial lift, facial peels, excisional facial surgery, dermal photorejuvenation, oral or maxillofacial surgery, etc.) that may interfere with the treatment area or evaluation within 6 months before screening as determined by the Principal Investigator.
• • The subject who received soft tissue augmentation at the treatment site at any time before screening as determined by the Principal Investigator.
• • Subjects with a scar or skin lesion at the treatment site that may interfere with the judgment of the treatment effect.
• • Subjects who participated in another clinical trial within 60 days before screening or plan to participate in another investigation during this study.
• • Subjects who plan to receive other wrinkle improvement treatments in the face during this trial.
• • Subjects who are otherwise determined by the investigator as ineligible for this study.